The Terry Fox Translational Research Program provides funding to Pan-Canadian projects that accelerate the development and adoption of new treatments and technologies for the benefit of cancer patients across Canada. These projects tackle a wide variety of cancer topics, spanning from early detection and screening to diagnosis, treatment and monitoring of treatment.
Translation is often defined as research which moves discoveries made in the clinic to the laboratory and then back to the bedside. It is sometimes called “applied” research. This area of research holds great promise today for providing improved care and outcomes for cancer patients everywhere. Translational research is focused on speeding up the development and adoption of new treatments and technologies for the benefit of cancer patients and their families, the healthcare system and for the population at large. It covers the spectrum of cancer research from early detection and screening to diagnosis, treatment and monitoring of treatment. Translational research has been underfunded in the past partly because it is complex, involves many different disciplines and stakeholders, and is usually expensive to do.
We are currently not taking new applications for this program.